Posted inBusiness News Entrepreneurship Investments
These 4 charts show the scale of Novo Nordisk’s woes
Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe's most valuable company.But its troubles are stacking up and today the stock trades…






